These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 20088842)

  • 41. Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy.
    Sait S; Zaghloul N; Patel A; Shah T; Iacobas I; Calderwood S
    Pediatr Blood Cancer; 2014 Dec; 61(12):2319-20. PubMed ID: 25154390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron overload in MDS-pathophysiology, diagnosis, and complications.
    Gattermann N; Rachmilewitz EA
    Ann Hematol; 2011 Jan; 90(1):1-10. PubMed ID: 20938663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iron overload and chelation therapy in myelodysplastic syndromes.
    Temraz S; Santini V; Musallam K; Taher A
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):64-73. PubMed ID: 24529413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral iron chelators and the treatment of iron overload in pediatric patients with chronic anemia.
    Vichinsky E
    Pediatrics; 2008 Jun; 121(6):1253-6. PubMed ID: 18519495
    [No Abstract]   [Full Text] [Related]  

  • 46. Iron-chelating therapy for transfusional iron overload.
    Taccone-Gallucci M; Manca-di-Villahermosa S; Noce A
    N Engl J Med; 2011 Apr; 364(15):1476-7; author reply 1477. PubMed ID: 21488786
    [No Abstract]   [Full Text] [Related]  

  • 47. Controversies surrounding iron chelation therapy for MDS.
    Leitch HA
    Blood Rev; 2011 Jan; 25(1):17-31. PubMed ID: 21030120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey.
    Vichinsky EP; Ohene-Frempong K;
    Pediatr Hematol Oncol; 2011 Feb; 28(1):37-42. PubMed ID: 20673029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of transfusional iron overload].
    Suzuki T
    Rinsho Ketsueki; 2020; 61(9):1205-1211. PubMed ID: 33162517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate.
    Imran F; Phatak P
    Expert Rev Hematol; 2017 Jan; 10(1):53-64. PubMed ID: 27923273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM; Cappellini MD; Taher AT
    Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes.
    Cazzola M; Della Porta MG; Malcovati L
    Hematology Am Soc Hematol Educ Program; 2008; ():166-75. PubMed ID: 19074076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry.
    Neukirchen J; Fox F; Kündgen A; Nachtkamp K; Strupp C; Haas R; Germing U; Gattermann N
    Leuk Res; 2012 Aug; 36(8):1067-70. PubMed ID: 22564985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving erythropoiesis: a compelling case for iron chelation in myelofibrosis.
    Pullarkat V
    Eur J Haematol; 2016 Jun; 96(6):549-50. PubMed ID: 26572646
    [No Abstract]   [Full Text] [Related]  

  • 55. Liver iron overload assessment by T *2 magnetic resonance imaging in pediatric patients: an accuracy and reproducibility study.
    Cheng HL; Holowka S; Moineddin R; Odame I
    Am J Hematol; 2012 Apr; 87(4):435-7. PubMed ID: 22286974
    [No Abstract]   [Full Text] [Related]  

  • 56. Hypoplastic anemia in cartilage-hair hypoplasia-balancing between iron overload and chelation.
    Taskinen M; Toiviainen-Salo S; Lohi J; Vuolukka P; Gräsbeck M; Mäkitie O
    J Pediatr; 2013 Apr; 162(4):844-9. PubMed ID: 23140882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.
    Harmatz P; Butensky E; Quirolo K; Williams R; Ferrell L; Moyer T; Golden D; Neumayr L; Vichinsky E
    Blood; 2000 Jul; 96(1):76-9. PubMed ID: 10891433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Iron dysregulation and anemias].
    Ikuta K
    Rinsho Ketsueki; 2015 Oct; 56(10):1903-13. PubMed ID: 26458428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia.
    Unal S; Cetin M; Hazirolan T; Yildirim G; Meral A; Birbilen A; Karabulut E; Aytac S; Tavil B; Kuskonmaz B; Tuncer M; Gumruk F
    Leuk Res; 2014 Aug; 38(8):882-5. PubMed ID: 24933623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transfusion-associated iron overload.
    Hollán SR
    Curr Opin Hematol; 1997 Nov; 4(6):436-41. PubMed ID: 9359002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.